ABSTRACT
RATIONALE & OBJECTIVE: Chronic kidney disease of unknown etiology (CKDUE) is one of the main global causes of kidney failure. Genetic studies may identify an etiology in these patients, but few studies have implemented genetic testing of CKDUE in a population-based series of patients, which was the focus of the GENSEN Study. STUDY DESIGN: Case series. SETTINGS & PARTICIPANTS: 818 patients aged≤45 years at 51 Spanish centers with CKDUE, and either an estimated glomerular filtration rate of<15mL/min/1.73m2 or treatment with maintenance dialysis or transplantation. OBSERVATIONS: Genetic testing for 529 genes associated with inherited nephropathies using high-throughput sequencing (HTS). Pathogenic and/or likely pathogenic (P/LP) gene variants concordant with the inheritance pattern were detected in 203 patients (24.8%). Variants in type IV collagen genes were the most frequent (COL4A5, COL4A4, COL4A3; 35% of total gene variants), followed by NPHP1, PAX2, UMOD, MUC1, and INF2 (7.3%, 5.9%, 2.5%, 2.5%, and 2.5%, respectively). Overall, 87 novel variants classified as P/LP were identified. The top 5 most common previously undiagnosed diseases were Alport syndrome spectrum (35% of total positive reports), genetic podocytopathies (19%), nephronophthisis (11%), autosomal dominant tubulointerstitial kidney disease (7%), and congenital anomalies of the kidney and urinary tract (CAKUT, 5%). A family history of kidney disease was reported by 191 participants (23.3%) and by 65 of 203 patients (32.0%) with P/LP variants. LIMITATIONS: Missing data, and selection bias resulting from voluntary enrollment. CONCLUSIONS: Genomic testing with HTS identified a genetic cause of kidney disease in approximately one quarter of young patients with CKDUE and advanced kidney disease. These findings suggest that genetic studies are a potentially useful tool for the evaluation of people with CKDUE. PLAIN-LANGUAGE SUMMARY: The cause of kidney disease is unknown for 1 in 5 patients requiring kidney replacement therapy, reflecting possible prior missed treatment opportunities. We assessed the diagnostic utility of genetic testing in children and adults aged≤45 years with either an estimated glomerular filtration rate of<15mL/min/1.73m2 or treatment with maintenance dialysis or transplantation. Genetic testing identified the cause of kidney disease in approximately 1 in 4 patients without a previously known cause of kidney disease, suggesting that genetic studies are a potentially useful tool for the evaluation of these patients.
ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Young Adult , Middle Aged , Aged , Photopheresis/methods , Graft Rejection/therapy , Kidney Transplantation/adverse effects , Retrospective Studies , Risk Factors , Creatinine/blood , Treatment Outcome , Reproducibility of ResultsABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Solitary Pulmonary Nodule/diagnostic imaging , Solitary Pulmonary Nodule/microbiology , Kidney Transplantation/adverse effects , Cryptococcosis/diagnostic imaging , Cryptococcosis/complications , Tomography, X-Ray ComputedSubject(s)
Graft Rejection/therapy , Kidney , Photopheresis/methods , Transplant Recipients , Chronic Disease , Female , Humans , Immunity, Cellular , Kidney Transplantation , Male , Middle Aged , Retrospective Studies , Young AdultABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Diuretics/therapeutic use , Metformin/pharmacokinetics , Acidosis, Lactic/chemically induced , Metformin/adverse effects , Renal Dialysis/methods , Diuretics/pharmacokineticsSubject(s)
Acidosis, Lactic/chemically induced , Diuretics/adverse effects , Hypoglycemic Agents/adverse effects , Metformin/adverse effects , Acidosis, Lactic/metabolism , Acidosis, Lactic/therapy , Acute Kidney Injury/physiopathology , Acute Kidney Injury/therapy , Aged , Contraindications, Drug , Diuretics/administration & dosage , Diuretics/metabolism , Female , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/metabolism , Male , Metformin/administration & dosage , Metformin/metabolism , Renal DialysisABSTRACT
No disponible